Both in Pharmaceuticals
Aktis Oncology vs Alumis
Over the past year AKTS returned −33.3% and ALMS returned −66.8%; their daily moves had a correlation of 0.15.
AKTS −33.3% ALMS −66.8%Growth of $1, one year, split-adjusted
| Metric | AKTS | ALMS |
|---|---|---|
| Price | $14.94 | $6.50 |
| Market cap | $831.0M | $841.3M |
| Today | +2.40% | +1.88% |
| 1 month | −19.3% | −5.0% |
| 6 months | −23.1% | −75.1% |
| Year to date | — | −33.4% |
| 1 year | — | +36.8% |
| Revenue growth (YoY) | — | −37.7% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −713.5% | −8557.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 113.7× |
| Net cash | $517.3M | $502.3M |
| Dividend yield | — | — |
| Volatility (60d) | 55.5% | 180.4% |
| Short % of float | 18.3% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).